MATERIALS OF VII ALL-RUSSIAN GMP-CONFERENCE
PRESENTATIONS
- Ashraf Hossain — Challenges of Implementation of Good Pharmacovigilance Practice in Bangladesh
- Burenkov — Training inspections as a tool for GxP implementation and development
- Chinara Myrzakmatovna Mambetalieva — Development of the EAEU Common Drug Market as Part of the 2025 Strategic Directions
- D.A. Rozhdestvensky, PhD. — Overview of Approved Key EEC Measures and Resolutions in the Period of 2021-2022
- Delgado J. — Good Distribution Practice New logistics chains, supply chains and sales channels
- Dmitry Vladimirovich Somov — Tests of medicines upon batch release Features of 2022
- Du Zin — Updates of GMP and Related Guidelines in China
- Elena Borisovna Lavnik — Problematic Issues of Enforcing the EAEU Good Manufacturing Practice when Planning, Organizing, Conducting GMP Inspections, Exchange of Results
- Gargubi L. — Tunisian Inspection requirements for manufacturing of drugs containing high-potent substances in shared facilities
- Gegechkori Vladimir — Reference Impurity Standards As An Adequate Approach to Drug Quality Control
- Gripvash — Elemental impurities. Practical application of ICH Q3D (R2) requirements
- Hasmik Abrahamyan — Transition from national GMP guidelines to a unified decision of the EAEU № 77: experience in passing audits
- Kedrin — Resolution
- Krasheninnikov A.E. — Regulatory features of the drug safety monitoring system in the context of geopolitical change
- Luborich M. — GxP implementation in Montenegro – benefits and challenges in post COVID era
- M.M. Ponomaryova — Good Pharmacy Practice as Basis for Retail Sales and Distribution of Drugs in the Republic of Belarus
- Makarov V. — Laboratory Stage of the Pharmaceutical Development as the Basis of the Drug Product Quality and Efficacy
- Mendiola F. — Good Distribution Practices (GDP inspections in the Philippines)
- Musaeva — Registration of Medicines in the Kyrgyz Republic
- N.T. Abdyrasulova — Import of Medicines. Responsibility
- Nataliya Popova — Main Stages of Pharmaceutical Inspection of Manufacture of Medicinal Products for Human Use
- Ozul Filiz — Quality at all stages of drug production and at every stage of drug development Türkiye Medicines and Medical Devices Agency’s view
- Ph. Mahmoud Al Qawasmeh — The Role of JFDA in Ensuring the Quality and Efficacy of Medicines in Jordan Market
- Puvan Deon — Unifying effects of an internationally-aligned local GCP standard
- Sottaeva M. — MUTUAL RECOGNITION OF GMP CERTIFICATES IN THE EAEU
- T.L. Tumelya — Problematic Issues of Drug Quality Control during Registration in the EAEU
- Tatyana Ivanovna Sitko — Topic: Experience in the Implementation of the Good Distribution Practice of the Eurasian Economic Union in the Republic of Belarus
- Victoria Presnyakova — Format and Development of Pharmacy Inspectorate and GPP Practices in the Modern Russian Realities
- Zh. Ordabekova — Transition to Supranational System of Inspection. Experience of the Republic of Kazakhstan